Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site revision updated from v3.4.2 to v3.4.3. This appears to be a minor update with no user-facing content changes to the study page.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:04.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Amyloidosis topic and a Genetic and Rare Diseases Information Center resource link; page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:54:15.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1; no changes to the Study Details content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI changes include a glossary toggle and new metadata rows (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The older lowercase wording (Last Update Submitted that met QC Criteria) and the prior revision (Revision: v3.3.4) were removed.
    Difference
    0.2%
    Check dated 2026-01-28T19:58:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. No core content, layout, or functional changes were made; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:44:30.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page footer, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:41:00.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.